Cargando…

Effects of tirofiban on the reperfusion-related no-reflow in rats with acute myocardial infarction

OBJECTIVE: To investigate the effects of tirofiban on the no-reflow phenomenon of acute myocardial infarction (AMI) rats received reperfusion, as well as the underlying mechanisms. METHODS: Fifty-six male Sprague-Dawley rats were randomly divided into four groups: Sham operation group (Sham), AMI/re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiao, Tao, Gui-Zhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627702/ https://www.ncbi.nlm.nih.gov/pubmed/23610574 http://dx.doi.org/10.3969/j.issn.1671-5411.2013.01.009

Ejemplares similares

Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon
por: Qin, Tao, et al.
Publicado: (2013)

No-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial Infarction
por: Lim, Sang Yup
Publicado: (2016)

Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion
por: Zhao, X.J., et al.
Publicado: (2014)

Tirofiban usage and prognosis after myocardial infarction
por: Eyüboğlu, Mehmet
Publicado: (2016)

Intravascular Ultrasound Observation of the Mechanism of No-Reflow Phenomenon in Acute Myocardial Infarction
por: Li, Junxia, et al.
Publicado: (2015)

The effects of Anisodamine-Tirofiban Combined Therapy in acute myocardial infarction treated with Percutaneous Coronary Intervention (PCI)
por: Jiao, Yan, et al.
Publicado: (2022)

Mechanisms of the “No-Reflow” Phenomenon After Acute Myocardial Infarction: Potential Role of Pericytes
por: Kaul, Sanjiv, et al.
Publicado: (2022)

Tirofiban hydrochloride sodium chloride injection combined with cardiovascular intervention in the treatment of Acute Myocardial Infarction
por: Liu, Yongxuan, et al.
Publicado: (2020)

Influence of Tirofiban maintenance duration on patients with acute myocardial infarction treated by percutaneous coronary intervention
por: Ji, Zhen-Guo, et al.
Publicado: (2015)

No-reflow phenomenon and in vivo cholesterol crystals combined with lipid core in acute myocardial infarction()
por: Katayama, Yosuke, et al.
Publicado: (2022)

Application of tirofiban in patients with acute myocardial infarction complicated with diabetes and undergoing emergency interventional therapy
por: Tang, Xiuying, et al.
Publicado: (2022)

Effects of no-reflow phenomenon on ventricular systolic synchrony in patients with acute anterior myocardial infarction after percutaneous coronary intervention
por: Wang, Le, et al.
Publicado: (2016)

A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention
por: Zeng, Qian, et al.
Publicado: (2020)

Evaluation of related factors, prediction and treatment drugs of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction after direct PCI
por: Li, Hui, et al.
Publicado: (2018)

Post-myocardial Infarction Ventricular Septal Defect in the Setting of No-Reflow and COVID
por: Riaz, Abdul Haseeb, et al.
Publicado: (2023)

Vagal nerve stimulation started just prior to reperfusion limits infarct size and no-reflow
por: Uitterdijk, André, et al.
Publicado: (2015)

No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient
por: Buono, Andrea, et al.
Publicado: (2019)

MRI evaluation of the role of No-Reflow in left ventricular remodeling after Acute Myocardial Infarction (AMI)
por: Liguori, Carlo, et al.
Publicado: (2009)

Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Cheng, Chao, et al.
Publicado: (2019)

Predicting coronary no-reflow in patients with acute ST-segment elevation myocardial infarction using Bayesian approaches
por: Zhang, Dongfeng, et al.
Publicado: (2014)

Intracoronary pressure gradient measurement in acute myocardial infarction patients with the no-reflow phenomenon during primary percutaneous coronary intervention
por: Gao, Ming-Dong, et al.
Publicado: (2020)

Analysis of the Best Timing for Applying Tirofiban in PCI Operation for the Patients with ST Segment Elevation Myocardial Infarction
por: Lei, Zhang, et al.
Publicado: (2015)

Factors related to the use of reperfusion strategies in elderly patients with acute myocardial infarction
por: Yi, Gui-yan, et al.
Publicado: (2014)

Reperfused hemorrhagic myocardial infarction in rats
por: Nair, Anand R., et al.
Publicado: (2020)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

Percutaneous Cardiopulmonary Support in Refractory No-Reflow with Cardiogenic Shock after Coronary Stenting in Acute Myocardial Infarction
por: Son, Jung-Woo, et al.
Publicado: (2010)

Comparison of no-reflow phenomenon after percutaneous coronary intervention for acute myocardial infarction between smokers and nonsmokers
por: Shemirani, Hassan, et al.
Publicado: (2014)

Predictors of no- reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum
por: Sabin, Padmajan, et al.
Publicado: (2017)

Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention
por: Wang, Haixia, et al.
Publicado: (2020)

Suppression of NF-κB Reduces Myocardial No-Reflow
por: Zeng, Min, et al.
Publicado: (2012)

Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Qi, Qi, et al.
Publicado: (2018)

In-Lab Upfront Use of Tirofiban May Reduce the Occurrence of No-Reflow During Primary Percutaneous Coronary Intervention. A Pilot Randomized Study
por: Lago, Igor Matos, et al.
Publicado: (2016)

Subacute Myocardial Rupture Following Tirofiban Treatment
por: Çiftçi, Özgür, et al.
Publicado: (2013)

The Effects of Ticagrelor Combined with Tirofiban on Coagulation Function, Serum Myocardial Injury Markers, and Inflammatory Factor Levels in Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention
por: Li, Fang, et al.
Publicado: (2022)

Effect of Early Treatment With Tirofiban on Initial TIMI Grade 3 Flow of Patients With ST Elevation Myocardial Infarction
por: Salarifar, Mojtaba, et al.
Publicado: (2014)

Effects of tirofiban on stent thrombosis, Hs-CRP, IL-6 and sICAM-1 after PCI of acute myocardial infarction
por: Zhang, Yuqing, et al.
Publicado: (2018)

Protective effect of Danhong injection in patients with acute myocardial infarction at a high risk of no-reflow during primary percutaneous coronary intervention
por: You, Qi, et al.
Publicado: (2019)

Myocardial infarction size as an independent predictor of intramyocardial haemorrhage in acute reperfused myocardial ischaemic rats
por: Xia, Rui, et al.
Publicado: (2022)

Efficacy and Safety of Thrombectomy Combined with Intracoronary Administration of Tirofiban in ST-segment Elevation Myocardial Infarction (STEMI)
por: Gao, Lu, et al.
Publicado: (2016)

The Clinical Efficacy of Tirofiban Combined with Ticagrelor and Aspirin in Treating Acute Myocardial Infarction by Percutaneous Coronary Intervention and Its Effect on Patients' Cardiac Function
por: Peng, Rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ih54ns891h9u7a981l3pl38eso